Investment

BRIDGEBIO PHARMA INC

Historical 13F holders

CUSIP
10806XAB8
Type
Debt
Class
NOTE 2.500% 3/1
Period 13F filings
2026 Q1 1
2025 Q4 2
2025 Q3 3
2025 Q2 3
2025 Q1 4
2024 Q4 1
2024 Q3 2